Literature DB >> 2516858

Nisin inhibits several gram-positive, mastitis-causing pathogens.

J R Broadbent1, Y C Chou, K Gillies, J K Kondo.   

Abstract

Organisms known to cause bovine mastitis, Enterococcus faecalis ssp. liquefaciens ATCC 27959, Staphylococcus aureus ATCC 29740, Streptococcus agalactiae ATCC 27956, Streptococcus equinus ATCC 27960, Streptococcus dysgalactiae ATCC 27957, Streptococcus uberis ATCC 27958, and the neotype Staphylococcus epidermidis ATCC 14990 were examined for their susceptibility to the small peptide antibiotic, nisin. Using a disc assay, minimum inhibitory concentrations of nisin ranged from 10 to 250 micrograms/ml among the strains. Examination of the antimicrobial effect of 50 micrograms/ml nisin in milk showed nisin inhibited all gram-positive pathogens tested.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2516858     DOI: 10.3168/jds.S0022-0302(89)79496-0

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  12 in total

Review 1.  Bacteriocin diversity in Streptococcus and Enterococcus.

Authors:  Ingolf F Nes; Dzung B Diep; Helge Holo
Journal:  J Bacteriol       Date:  2006-11-10       Impact factor: 3.490

2.  Evaluation of lacticin 3147 and a teat seal containing this bacteriocin for inhibition of mastitis pathogens.

Authors:  M P Ryan; W J Meaney; R P Ross; C Hill
Journal:  Appl Environ Microbiol       Date:  1998-06       Impact factor: 4.792

3.  Comparison of the Potency of the Lipid II Targeting Antimicrobials Nisin, Lacticin 3147 and Vancomycin Against Gram-Positive Bacteria.

Authors:  Catalin Iancu; Aoife Grainger; Des Field; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  Probiotics Antimicrob Proteins       Date:  2012-06       Impact factor: 4.609

4.  Update on the development of a novel dry cow therapy using a bismuth-based intramammary teat seal in combination with the bacteriocin lacticin 3147.

Authors:  Fiona Crispie; James Flynn; R Paul Ross; Colin Hill; William J Meaney
Journal:  Ir Vet J       Date:  2004-11-01       Impact factor: 2.146

Review 5.  Nisin Variants Generated by Protein Engineering and Their Properties.

Authors:  Yue Zheng; Yuhui Du; Zekai Qiu; Ziming Liu; Jianjun Qiao; Yanni Li; Qinggele Caiyin
Journal:  Bioengineering (Basel)       Date:  2022-06-10

6.  Molecular and genetic characterization of a novel nisin variant produced by Streptococcus uberis.

Authors:  Ruth E Wirawan; Nikolai A Klesse; Ralph W Jack; John R Tagg
Journal:  Appl Environ Microbiol       Date:  2006-02       Impact factor: 4.792

7.  In vitro synergistic activities of cefazolin and nisin A against mastitis pathogens.

Authors:  Kohei Kitazaki; Shoko Koga; Kohei Nagatoshi; Koichi Kuwano; Takeshi Zendo; Jiro Nakayama; Kenji Sonomoto; Hitoshi Ano; Hiromu Katamoto
Journal:  J Vet Med Sci       Date:  2017-07-29       Impact factor: 1.267

8.  The lantibiotic gallidermin acts bactericidal against Staphylococcus epidermidis and Staphylococcus aureus and antagonizes the bacteria-induced proinflammatory responses in dermal fibroblasts.

Authors:  Torbjörn Bengtsson; Johanna Lönn; Hazem Khalaf; Eleonor Palm
Journal:  Microbiologyopen       Date:  2018-03-13       Impact factor: 3.139

9.  Saturation mutagenesis of lysine 12 leads to the identification of derivatives of nisin A with enhanced antimicrobial activity.

Authors:  Evelyn M Molloy; Des Field; Paula M O' Connor; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

10.  Mode of action and In Vitro susceptibility of mastitis pathogens to macedocin ST91KM and preparation of a teat seal containing the bacteriocin.

Authors:  Renee Pieterse; Svetoslav D Todorov; Dicks Leon M T
Journal:  Braz J Microbiol       Date:  2010-03-01       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.